Biosyngen's BST02, the World's First TIL Therapy for Liver Cancer, is Granted an IND Approval by FDA
SINGAPORE, Oct. 26, 2023 /PRNewswire/ -- On October 26, 2023, Biosyngen's TIL therapy BST02 for liver cancer was granted an approval for clinical trial by the US FDA. BST02, a breakthrough product in the field of cell and gene therapy, represents...
Zepp Health Sponsors Cal Hacks 10.0, the World's Largest Collegiate Hackathon, for the Second Consecutive Year
- Winners with the best apps will receive Zepp's Amazfit smartwatches and cash award MILPITAS, Calif., Oct. 19, 2023 /PRNewswire/ -- Zepp Health Corporation, a global leader in smart wearables and health technology, is excited to announce its...
